These findings are in close agreement with the results of Li et al., who showed that knockdown of SREBP-1 expression in endometrial cancer cells suppressed cell growth, reduced colonigenic capacity, and slowed tumor growth in vivo [42]. This evidence concerns the gene SREBF1 and endometrial cancer.